Asgard Therapeutics has appointed Prof Dr Wolfram Brugger as Chief Medical Officer, strengthening its leadership team as the ...
I’m sure many readers will relate to Kylie’s observation that approval procedures can unintentionally iron out the novel ...
The MHRA is establishing a new hub in Northern Ireland to support the region’s fast‑growing life sciences sector, in a move ...
Novo Nordisk has presented new sub‑analyses from the phase 3 OASIS 4 trial at ECO2026, showing that oral semaglutide 25mg ...
Enterprise Therapeutics has reported that its phase 2 trial of ETD001, an investigational inhaled epithelial sodium channel ...
The Scottish medicines consortium has recommended the reimbursement of enfortumab vedotin with pembrolizumab for adults with ...
PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...
There is a growing disconnect between what the industry is offering in terms of digital customer experience and what ...
The conversation about AI in pharmacovigilance has typically focused on automating individual steps in the case processing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results